FPH - Fisher Paykel Healthcare.

[ratkin]

FISHER & PAYKEL HEALTHCARE INTRODUCES NEW CPAP RANGE


Rather unfortunate name
It had better be good , or we know what the nurses will be calling it

[Lizard]

Yes, I too choked on my coffee when skim-reading the announcements this morning...

Fortunately, the newspapers, more thoughtfully, translated the headline to read "F&P Launches New Sleep Apnea Product"

[Zito]

Will be interesting to see what effect the Obama health care reform bill has ... should be good.

I'm not so sure it will be good for FPH but it's too early to tell. The US Senate, in passing the ObamaCare Health Plan into law, also imposed a 2.3% excise tax on most medical devices.

Reaction from the industry has been mixed, at best. There is the risk that it will impact growth and place a premium on future research and innovation.

FPH will have been monitoring the passage of the legislation carefully. With about 40% of the company's sales in the US, they will be affected, and if they cannot pass on the tax its NPAT in the States could fall by a significant amount. We shall see.

[Catalyst]

This from CEO Mike Daniell:

Fisher & Paykel Healthcare (FPH): Chief executive Mike Daniell said US President Barack Obama’s healthcare reforms are a long-term positive for his company though it may take several years to bear fruit, according to BusinessDay.

It's interesting to compare Resmed (RMD.AU) with FPH. The two stocks operate in the sleep apnea market and normally track quite closely. I've noticed over the past six months RMD has taken off (+30%) and FPH has dropped (-5%), which is unusual.

[elZorro]

There's a slight uptick on the FPH share price these days. There are some interesting comments in the sleep apnea blogosphere about the new ICON range.

http://www.sleepguide.com/forum/topi...ource=activity

http://www.sleepzone.com.au/showitem...heading1=CPAPs

The indication is that there is some demand for this new gear, and of course USA and Europe is where the action is, not Australasia. I would guess that after a bit of customer testing/evaluation in the local field, the overseas markets will be followed up.

I've heard on the grapevine that the ICON product is very classy looking. Would now be a good time to buy FPH?

[percy]

. Would now be a good time to buy FPH?[/QUOTE]
I would look at TA.On fundamentals I think it is a very good company.It is in the health sector,has good products,has a vegry high ROIC of over 20%.Has excellent growth prospects and invests a good deal on research which is coming through with new and better products.We may even see more drugs in future delivered via the lungs which may benefit FPH.I own a few however I class them as a long term hold.

[elZorro]

Thanks for that Percy, I'm not so good at TA (or FA for that matter) but I will have a look.

I was shown just one locally-made piece of the ICON product last week, and the attention to detail was extraordinary. If all of it has been crafted like that, it's a product we'd all be proud to call NZ Made. When FPH first floated after the split, I knew there were good engineers there, but wasn't into buying shares. It would have been a good investment though.

So now here we are with the share price dropped back somewhat, and all indications are that a new product might steal a march on the competitors. I wonder if they have any patents covering the concept internationally.

[Silverlight]

Weekly chart attached.

Solid uptrend with 3.50 a pretty significant technical level, long term a break out above $3.50 could be expected, buy on the breakout, or the re-test of the support/resistance level, if it retests.

[Penfold]

This is one of my long term holds... I don't trade like most of the guys on here.

I have been watching this for years and there seems to be something up that you TA guys might want to look at. FPH is moving up pretty solidly these last few days despite the xrate not going in their favour. This is pretty unusual behavior... Just thought I would mention it because I don't contribute much round here being a FA kind of guy.

[winner69]

Sokid at best result

Headlines say profit up 15% to $71m

However operating profit about the same as last year. Profit increase from forex movements

Guidance is for about the same profit next year so not expecting much growth .... which says the headline about this years profit is not indicative of an another good year .... and with a shareprice at 24 times earnings doesn't suggest outperformance of returns over the next few years